Parathyroid hormone-related protein as a common target molecule in specific immunotherapy for a wide variety of tumor types

Yoshimi Arima, Satoko Matsueda, Hirohisa Yano, Mamoru Harada, Kyogo Itoh

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Parathyroid hormone-related protein (PTH-rP) has been considered to be responsible for malignancy-associated hypercalcemia and is thought to participate in pathological changes in bone metastases of cancer. In this study, we determined whether or not PTH-rP could be a common target molecule in specific immunotherapy for patients with a wide variety of tumor types. Various types of tumor cell lines were examined for PTH-rP expression at the mRNA and protein levels by RT-PCR, flow cytometry, and immunocytochemistry. We also determined whether or not cancer-reactive cytotoxic T lymphocytes (CTLs) could be induced from the peripheral blood mononuclear cells (PBMCs) of HLA-A24 + patients with gastric, colon, renal, or cervical cancer by in vitro stimulation with two PTH-rP peptides. As a result, PTH-rP mRNA was expressed in the majority of gastric, breast, lung, colon, cervical, and renal cancer cell lines. Expression of the protein was confirmed by both flow cytometry and immunocytochemistry. Furthermore, PTH-rP peptide-specific and cancerreactive CTLs were successfully generated from the PBMCs of HLA-A24+ patients with different tumor types using in vitro stimulation with either the PTH-rP102-111 or PTH-rP, 110-119 peptide. These findings indicate that PTH-rP could be a common target molecule in specific immunotherapy for patients with a wide variety of tumor types, particularly bone metastases.

Original languageEnglish
Pages (from-to)981-988
Number of pages8
JournalInternational Journal of Oncology
Volume27
Issue number4
Publication statusPublished - 2005 Oct 1
Externally publishedYes

Fingerprint

Parathyroid Hormone-Related Protein
Immunotherapy
Neoplasms
HLA-A24 Antigen
Kidney Neoplasms
Cytotoxic T-Lymphocytes
Uterine Cervical Neoplasms
Colonic Neoplasms
Blood Cells
Flow Cytometry
Immunohistochemistry
Neoplasm Metastasis
Bone Neoplasms
Messenger RNA
Hypercalcemia
Tumor Cell Line
Stomach Neoplasms
Lung Neoplasms
Stomach
Proteins

Keywords

  • Cytotoxic T lymphocytes
  • HLA-A24
  • Immunotherapy
  • Parathyroid hormone-related protein
  • Peptide

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Parathyroid hormone-related protein as a common target molecule in specific immunotherapy for a wide variety of tumor types. / Arima, Yoshimi; Matsueda, Satoko; Yano, Hirohisa; Harada, Mamoru; Itoh, Kyogo.

In: International Journal of Oncology, Vol. 27, No. 4, 01.10.2005, p. 981-988.

Research output: Contribution to journalArticle

Arima, Yoshimi ; Matsueda, Satoko ; Yano, Hirohisa ; Harada, Mamoru ; Itoh, Kyogo. / Parathyroid hormone-related protein as a common target molecule in specific immunotherapy for a wide variety of tumor types. In: International Journal of Oncology. 2005 ; Vol. 27, No. 4. pp. 981-988.
@article{5dd27ed7fee5403dba990477a0dba4e7,
title = "Parathyroid hormone-related protein as a common target molecule in specific immunotherapy for a wide variety of tumor types",
abstract = "Parathyroid hormone-related protein (PTH-rP) has been considered to be responsible for malignancy-associated hypercalcemia and is thought to participate in pathological changes in bone metastases of cancer. In this study, we determined whether or not PTH-rP could be a common target molecule in specific immunotherapy for patients with a wide variety of tumor types. Various types of tumor cell lines were examined for PTH-rP expression at the mRNA and protein levels by RT-PCR, flow cytometry, and immunocytochemistry. We also determined whether or not cancer-reactive cytotoxic T lymphocytes (CTLs) could be induced from the peripheral blood mononuclear cells (PBMCs) of HLA-A24 + patients with gastric, colon, renal, or cervical cancer by in vitro stimulation with two PTH-rP peptides. As a result, PTH-rP mRNA was expressed in the majority of gastric, breast, lung, colon, cervical, and renal cancer cell lines. Expression of the protein was confirmed by both flow cytometry and immunocytochemistry. Furthermore, PTH-rP peptide-specific and cancerreactive CTLs were successfully generated from the PBMCs of HLA-A24+ patients with different tumor types using in vitro stimulation with either the PTH-rP102-111 or PTH-rP, 110-119 peptide. These findings indicate that PTH-rP could be a common target molecule in specific immunotherapy for patients with a wide variety of tumor types, particularly bone metastases.",
keywords = "Cytotoxic T lymphocytes, HLA-A24, Immunotherapy, Parathyroid hormone-related protein, Peptide",
author = "Yoshimi Arima and Satoko Matsueda and Hirohisa Yano and Mamoru Harada and Kyogo Itoh",
year = "2005",
month = "10",
day = "1",
language = "English",
volume = "27",
pages = "981--988",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - Parathyroid hormone-related protein as a common target molecule in specific immunotherapy for a wide variety of tumor types

AU - Arima, Yoshimi

AU - Matsueda, Satoko

AU - Yano, Hirohisa

AU - Harada, Mamoru

AU - Itoh, Kyogo

PY - 2005/10/1

Y1 - 2005/10/1

N2 - Parathyroid hormone-related protein (PTH-rP) has been considered to be responsible for malignancy-associated hypercalcemia and is thought to participate in pathological changes in bone metastases of cancer. In this study, we determined whether or not PTH-rP could be a common target molecule in specific immunotherapy for patients with a wide variety of tumor types. Various types of tumor cell lines were examined for PTH-rP expression at the mRNA and protein levels by RT-PCR, flow cytometry, and immunocytochemistry. We also determined whether or not cancer-reactive cytotoxic T lymphocytes (CTLs) could be induced from the peripheral blood mononuclear cells (PBMCs) of HLA-A24 + patients with gastric, colon, renal, or cervical cancer by in vitro stimulation with two PTH-rP peptides. As a result, PTH-rP mRNA was expressed in the majority of gastric, breast, lung, colon, cervical, and renal cancer cell lines. Expression of the protein was confirmed by both flow cytometry and immunocytochemistry. Furthermore, PTH-rP peptide-specific and cancerreactive CTLs were successfully generated from the PBMCs of HLA-A24+ patients with different tumor types using in vitro stimulation with either the PTH-rP102-111 or PTH-rP, 110-119 peptide. These findings indicate that PTH-rP could be a common target molecule in specific immunotherapy for patients with a wide variety of tumor types, particularly bone metastases.

AB - Parathyroid hormone-related protein (PTH-rP) has been considered to be responsible for malignancy-associated hypercalcemia and is thought to participate in pathological changes in bone metastases of cancer. In this study, we determined whether or not PTH-rP could be a common target molecule in specific immunotherapy for patients with a wide variety of tumor types. Various types of tumor cell lines were examined for PTH-rP expression at the mRNA and protein levels by RT-PCR, flow cytometry, and immunocytochemistry. We also determined whether or not cancer-reactive cytotoxic T lymphocytes (CTLs) could be induced from the peripheral blood mononuclear cells (PBMCs) of HLA-A24 + patients with gastric, colon, renal, or cervical cancer by in vitro stimulation with two PTH-rP peptides. As a result, PTH-rP mRNA was expressed in the majority of gastric, breast, lung, colon, cervical, and renal cancer cell lines. Expression of the protein was confirmed by both flow cytometry and immunocytochemistry. Furthermore, PTH-rP peptide-specific and cancerreactive CTLs were successfully generated from the PBMCs of HLA-A24+ patients with different tumor types using in vitro stimulation with either the PTH-rP102-111 or PTH-rP, 110-119 peptide. These findings indicate that PTH-rP could be a common target molecule in specific immunotherapy for patients with a wide variety of tumor types, particularly bone metastases.

KW - Cytotoxic T lymphocytes

KW - HLA-A24

KW - Immunotherapy

KW - Parathyroid hormone-related protein

KW - Peptide

UR - http://www.scopus.com/inward/record.url?scp=33644819810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644819810&partnerID=8YFLogxK

M3 - Article

VL - 27

SP - 981

EP - 988

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 4

ER -